ABOS Latest Headlines

Acumen Pharmaceuticals’ Earnings Call Pivots on ALTITUDE-AD

at www.tipranks.com (Mon, 26-Oct 8:08 PM)

Acumen Pharmaceuticals Reports Q3 Results, Alzheimer’s Pipeline Progress

at www.tipranks.com (Mon, 26-Oct 7:27 AM)

Acumen Pharmaceuticals GAAP EPS of -$0.35 beats by $0.02

at seekingalpha.com (Mon, 26-Oct 7:04 AM)

Maintains Buy on Acumen: Undervalued Alzheimer’s Opportunity with Sabirnetug and Unchanged $8 Price Target

at www.tipranks.com (Mon, 26-Oct 6:37 AM)